Title:
AGONISTIC ANTIBODIES SPECIFICALLY BINDING HUMAN CD40 AND METHODS OF USE
Document Type and Number:
WIPO Patent Application WO/2017/059243
Kind Code:
A3
Abstract:
The present invention relates to agonistic antibodies specifically binding human CD40, polynucleotides encoding the antibodies or antigen-binding fragments, and methods of making and using the foregoing.
Inventors:
FRANSSON JOHAN (CA)
KIM PAUL (US)
QUIGLEY MICHAEL (US)
SMITH ANDRESSA (US)
TEPLYAKOV ALEXEY (US)
ZHOU HONG (US)
KIM PAUL (US)
QUIGLEY MICHAEL (US)
SMITH ANDRESSA (US)
TEPLYAKOV ALEXEY (US)
ZHOU HONG (US)
Application Number:
PCT/US2016/054764
Publication Date:
June 08, 2017
Filing Date:
September 30, 2016
Export Citation:
Assignee:
JANSSEN BIOTECH INC (US)
International Classes:
C12N15/13; A61K39/395; A61P35/00; A61P35/02
Domestic Patent References:
| WO2014126254A1 | 2014-08-21 |
Foreign References:
| US20140120103A1 | 2014-05-01 | |||
| US20050202531A1 | 2005-09-15 | |||
| US20130243195A1 | 2013-09-19 | |||
| US20050054019A1 | 2005-03-10 | |||
| US20090104204A1 | 2009-04-23 | |||
| US20140178388A1 | 2014-06-26 | |||
| US20090311245A1 | 2009-12-17 |
Other References:
See also references of EP 3356532A4
Attorney, Agent or Firm:
SHIRTZ, Joseph F. et al. (US)
Download PDF: